J1

Ruan, L., X.H. Li, X.X. Wan, H. Yi, C. Li,  M.Y. Li, P.F. Zhang, G.Q. Zeng, J.Q. Qu, Q.Y. He, J.H. Li, Y. Chen, Z.C. Chen,  and Z.Q. Xiao, Analysis of EGFR signaling pathway in nasopharyngeal carcinoma  cells by quantitative phosphoproteomics. Proteome Sci, 2011. 9:35.

2011

Proteome Sci

2.48

J2

Zeng, G.Q., H. Yi, X.H. Li, H.Y. Shi, C. Li,  M.Y. Li, P.F. Zhang, X.P. Feng, X.X. Wan, J.Q. Qu, Y. Xu, Y. Sun, Z.C. Chen, and  Z.Q. Xiao, Identification of the proteins related to p53-mediated radioresponse  in nasopharyngeal carcinoma by proteomic analysis. J Proteomics, 2011.

2011

J Proteomics

5.07

J3

Liu J, Zhan X, Li M, Li G, Zhang P, Xiao Z,  Shao M, Peng F, Hu R, Chen Z. Mitochondrial proteomics of nasopharyngeal carcinoma  metastasis. BMC Medical Genomics, 2012, 5: 62 .

2012

BMC Medical Genomics

3.78

J4

Yi L, Li D, Li X, Deng J, Liao Y, Liang Y,  Chen Z, Xiao Z. Serum metabolic fingerprinting to detect human nasopharyngeal  carcinoma based on gas chromatography-mass spectrometry and partial least squares-linear  discriminant analysis. Analytical Letters, 2011, 44: 1473–1488.

2011

Analytical Letters

1.03

J5

Li M, Li C, Li D, Xie Y, Shi J, Li G, Guan  Y, Li M, Zhang P, Peng F, Xiao Z, Chen Z. Periostin, a stroma-associated protein,  correlates with tumor invasiveness and progression in nasopharyngeal carcinoma.  Clin Exp Metastasis. 2012 Dec;29(8):865-77.

2012

Clin Exp Metastasis

3.46

J6

Ge S, Mao Y, Yi Y, Xie D, Chen Z, Xiao Z.  Comparative proteomic analysis of secreted proteins from nasopharyngeal carcinoma-associated  stromal fibroblasts and normal fibroblasts. Exp Ther Med. 2012 May;3(5):857-860.  Epub 2012 Feb 13.

2012

Exp Ther Med

1.26

J7

Liu YF, Zhang PF, Li MY, Li QQ, Chen ZC.Identification  of annexin A1 as a proinvasive and prognostic factor for lung adenocarcinoma.  Clin Exp Metastasis. 2011 Jun;28(5):413-25.

2011

Clin Exp Metastasis

3.52

J8

Luo CH, Liu QQ, Zhang PF, Li MY, Chen ZC,  Liu YF. Prognostic significance of annexin II expression in non-small cell lung  cancer. Clin Transl Oncol. 2013 Nov;15(11):938-46.

2013

Clin Transl Oncol

1.6

J9

Zhang PF, Zeng GQ, Yi LZ, Liu JP, Wan XX,  Qu JQ, Li JH, Li C, Tang CE, Hu R, Ye X, Chen Y, Chen ZC, Xiao ZQ. Identification  of integrin β1 as a prognostic biomarker for human lung adenocarcinoma using 2D-LC-MS/MS  combined with iTRAQ technology. Oncol Rep. 2013 Jul;30(1):341-9.

2013

Oncol Rep

2.19

J10

Zhang PF, Zeng GQ, Hu R, Li C, Yi H, Li MY,  Li XH, Qu JQ, Wan XX, He QY, Li JH, Chen Y, Ye X, Li JY, Wang YY, Feng XP,  Xiao ZQ.Identification of flotillin-1 as a novel biomarker for lymph node metastasis  and prognosis of lung adenocarcinoma by quantitative plasma membrane proteome  analysis. J Proteomics. 2012 Dec 21;77:202-14.

2012

J Proteomics

4.08

J11

梁旭俊， 郭爱云， 陈主初， 卢光琇， 张鹏飞. 双水相纯化人肺腺癌和癌旁正常肺组织质膜蛋白质组差异分析.  中国生物化学与分子生物学报.2015  年2 月，31( 2) : 182～190

2015

中国生物化学与分子生物学报

J12

Zeng GQ, Yi H, Zhang PF, Li XH, Hu R, Li MY,  Li C, Qu JQ, Deng X, Xiao ZQ. The function and significance of SELENBP1 downregulation  in human bronchial epithelial carcinogenic process. PLoS One. 2013 Aug 19;8(8):e71865.

2013

PLoS One

3.53

J13

Zeng GQ, Zhang PF, Li C, Peng F, Li MY, Xu  Y, Yu FL, Chen MJ, Yi H, Li GQ, Chen ZC, Xiao ZQ. Comparative proteome analysis  of human lung squamous carcinoma using two different methods: two-dimensional  gel electrophoresis and iTRAQ analysis. Technol Cancer Res Treat. 2012 Aug;11(4):395-408.  Epub 2012 Mar 15.

2012

Technol Cancer Res Treat

1.94

J14

Zeng GQ, Zhang PF, Deng X, Yu FL, Li C, Xu  Y, Yi H, Li MY, Hu R, Zuo JH, Li XH, Wan XX, Qu JQ, He QY, Li JH, Ye X, Chen Y,  Li JY, Xiao ZQ.Identification of candidate biomarkers for early detection of human  lung squamous cell cancer by quantitative proteomics. Mol Cell Proteomics. 2012  Jun;11(6):M111.013946.

2012

Mol Cell Proteomics

7.25

J15

Dan He, Jun Wang, Chunfang Zhang, Bin  Shan, Xiyun Deng, Bin Li, Yanwu Zhou, Wei Chen, Jidong Hong, Yang Gao, Zhuchu  Chen, Chaojun Duan. Down-regulation of  miR-675-5p contributes  to  tumor  progression and development by  targeting pro-tumorigenic GPR55 in non-small cell lung cancer[J]. Molecular  Cancer, 2015, 14(1):1-14.

2015

Molecular Cancer

4.25

J16

BIN  LI,  JING  CHEN  LU,DAN  HE,JUN  WANG,HUI  ZHOU,LIANGFANG

SHEN,CHUNFANG ZHANG,and CHAOJUN DUAN. Rapid  onset lung squamous cell carcinoma with prominent peritoneal carcinomatosis and  an eosinophilic leukemoid reaction, with coexistence of the BRAF V600E and oncogenic  KRAS G12A mutations: A case report[J]. Oncology Letters, 2014, 8(2):589-593.

2014

Oncology Letters

1.55

J17

黄英，李茂玉，彭芳，肖哲锋，李圆圆，李国庆，李凌，邵美英，陈主初.人结肠癌与结肠腺瘤的定量蛋白质组学研究.中国医师杂志，2014；16（5）：592-6

2014

中国医师杂志

J18

Mu Y, Chen Y, Zhang G, Zhan X, Li Y, Liu T,  Li G, Li M, Xiao Z, Gong X and Chen Z. Identification of stromal differentially  expressed proteins in the colon carcinoma by quantitative proteomics. Electrophoresis.  2013; 34(11):1679-1692.

2013

Electrophoresis

3.16

J19

Liu T, Ye L, He Y, Chen X, Peng J, Zhang X,  Yi H, Peng F and Leng A. Combination gene therapy using VEGF-shRNA and fusion  suicide gene yCDglyTK inhibits gastric carcinoma growth. Exp Mol Pathol. 2011;  91(3):745-752.

2011

Exp Mol Pathol

2.42

J20

Peng F, Zhan X, Li MY, Fang F, Li G, Li  C, Zhang PF and Chen Z. Proteomic and bioinformatics analyses of mouse liver microsomes.  Int J Proteomics. 2012; 2012:832569.

2012

Int J Proteomics

J21

Fang Peng, Ying Huang, Mao-Yu Li, Guo-Qing  Li, Hui-Chao Huang, Rui Guan, Zhu-Chu Chen, Song-Ping Liang, Yong-Heng Chen.  Dissecting characteristics and dynamics of differentially expressed proteins during  multistage carcinogenesis of human colorectal cancer. World J Gastroenterol, 2016  May 14; 22(18): 4515-4528

2016

World J Gastroenterol

2.36

J22

Maoyu Li, Fang Peng, Guoqing Li, Yang Fu,  Ying Huang, Zhuchu Chen, Yongheng Chen. Proteomic analysis of stromal proteins  in different stages of colorectal cancer establishes Tenascin-C as a stromal biomarker  for colorectal cancer metastasis. Oncotarget, 2016, accepted.

2016

Oncotarget

6.35

J23

Zhan X, Desiderio DM, Wang X, Zhan X, Guo  T, Li M, Peng F, Chen X, Yang H, Zhang P, Li X, Chen Z. Identification of the  proteomic variations of invasive relative to noninvasive nonfunctional pituitary  adenomas. Electrophoresis, 2014,35 (15): 2184-2194.

2014

Electrophoresis

3.56

J24

Zhan X, Wang X, Long Y, Desiderio DM. Heterogeneity  analysis of the proteomes in clinically nonfunctional pituitary adenomas. BMC  Medical Genomics,2014,7: 69.

2014

BMC Medical Genomics

3.91

J25

Wang X, Guo T, Peng F, Long Y, Mu Y, Yang  H, Ye N, Li X, Zhan X . Proteomic and functional profiles of a follicle-stimulating  hormone-positive human nonfunctional pituitary adenoma. Electrophoresis, 2015,36  (11-12): 1289-1304.

2015

Electrophoresis

3.26

J26

Zhan X . Proteomic heterogeneity of nonfunctional  pituitary adenomas. Precision Medicine, 2015, 2: e663.

2015

Precision Medicine

J27

Zhan  X  .  Hormone-related  proteomic  and  functional  variations  in  human  nonfunctional pituitary adenomas. Inflammation and Cell Signaling,2015,2: e841.

2015

Inflammation and Cell Signaling

J28

Zhan X, Wang X, Desiderio DM. Pituitary adenoma  nitroproteomics:  current status and perspectives. Oxidative Medicine  and Cellular Longevity, 2013,2013: 580710.

2013

Oxidative Medicine and Cellular Longevity

3.43

J29

Zhan X, Wang X, Desiderio DM. Mass spectrometry  analysis of nitrotyrosine-containing proteins. Mass Spectrometry Reviews, 2015,34  (4): 423-448.

2015

Mass Spectrometry Reviews

8.05

J30

Hu  R,  Wang  X,  Zhan  X.  Multi-parameter  systematic  strategy  for  predictive,  preventive, and personalized medicine in cancer. EPMA-Journal, 2013,4: 2.

2013

EPMA-Journal

J31

Wang X, Hu R, Zhan X. Multi-parameter systematic  strategy of PPPM in cancer. Journal of Chinese Physician,2013,15 (7): 993-999.

2013

Journal of Chinese Physician

J32

Zhan X, Hu R, Wang X. Multi-parameter systematic  strategy opinion that predicts, prevents, and personalized treats a cancer. EPMA  Journal, 2014,5 (Suppl 1): A25.

2014

EPMA Journal

J33

Zhan X, Long Y. Exploration of molecular network  variations in different subtypes of human nonfunctional pituitary adenomas. Frontiers  in  Endocrinology,2016, 7:13.

2016

Frontiers in Endocrinology

J34

Grech G, Zhan X, Yoo BC, Bubnov R, Hagan S,  Danesi R, Vittadini G, DesiderioD. EPMA Position Paper in Cancer: Current overview  and future perspectives. EPMA J,2015,6: 9.

2015

EPMA J

J35

Zhan X. Systematic strategy opinion for research  and clinical practice of chronic diseases. International Journal of Chronic Disease  & Therapy, 2015,1(3e): 1-2.

2015

International Journal of Chronic Disease &  Therapy

J36

Zhan X. Current status of two-dimensional  gel electrophoresis and multi-dimensional liquid chromatography as proteomic separation  techniques. Annals of Chromatography and Separation Techniques,2015,1(2):1009.

2015

Annals of Chromatography and Separation Techniques

J37

Zhan X. Insight into protein variants/isoforms  and post-translational modifications in a proteome. Austin Proteomics,2015,2(1):  1009.

2015

Austin Proteomics

J38

Chen YH,Zhang XJ，Machado ACDM, Ding  Y，Chen ZC，Qin PZ，Rohs R，Chen L *[J].Structure of p53 binding to the BAX response element reveals  DNA unwinding and compression to accommodate base-pair insertion.，Nucleic Acids Research，2013，41（17）：8368-8376

2013

Nucleic Acids Research

8.8

J39

Yongheng Chen, Chunxia Chen, Zhe Zhang, Chun-Chi  Liu, Matthew E. Johnson, Celso A. Espinoza, Lee E. Edsall, Bing Ren, Xianghong  Jasmine Zhou, Struan

F.A. Grant, Andrew D. Wells and Lin Chen*  . DNA binding by FOXP3 domain-swapped dimer suggests mechanisms of long-range  chromosomal interactions [J]. Nucleic Acids Research, 2015, 43(2): 1268–1282

2015

Nucleic Acids Research

9.1

J40

Chen YL, Bates DL, Dey R, Chen PH, Machado  ACDM, Laird-Offringa I, Rohs R, Chen L. DNA Binding by GATA Transcription Factor  Suggests Mechanisms of DNA Looping and Long-Range Gene Regulation[J] Cell Report,  2012, 2:1197-1206

2012

Cell Report

8.3

J41

Duan YK，Chen L，Chen YH*，Fan XG，c-Src Binds to the  Cancer  Drug

Ruxolitinib with an Active Conformation[J].PLos  One，2014，9（9）: e106225

2014

Plos One

3.23

J42

Jayathilaka N, Han AD, Gaffney KJ, Dey R,  Jarusiewicz JA, Nordomi K, Philips MA, Lei X, He J, Ye J, Gao T, Petasis NA, Chen  L, Inhibition of the function of class IIa HDACs by blocking their interaction  with MEF2[J]. Nucleic Acids Research, 2012, 40(12): 5378–5388

2012

Nucleic Acids Research

8.27